Andrew Saik

Insider Reports History

Location
Chesterbrook, PA
Signature
/s/ Jared Freedberg, as attorney-in-fact for Andrew Saik
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Saik:

Form 4 holding Chief Financial Officer

ARVINAS, INC.

Security class
Common Stock
Shares / value
193,128
Estimated value
$1,919,190
Report date
11 May 2026
Price
$9.94
Ownership
Direct
Form 4 holding Chief Financial Officer

ARVINAS, INC.

Security class
Stock Option (right to buy)
Shares / value
67,000
Estimated value
$1,199,360
Report date
26 Feb 2026
Price
$16.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

VYNE Therapeutics Inc.

Security class
Common Stock
Shares / value
116,468
Estimated value
$265,547
Report date
28 May 2021
Price
$2.28
Ownership
Direct
Form 4 holding EVP & Chief Financial Officer

INTERCEPT PHARMACEUTICALS, INC.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
08 Nov 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Andrew Saik

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .